Keratoconus Progression: What to Expect and How to Monitor

How Keratoconus Progresses Over Time

How Keratoconus Progresses Over Time

Keratoconus is a condition in which the cornea gradually thins and bulges into a cone-like shape, causing distorted vision that can worsen over time. According to a 2024 study in the American Journal of Ophthalmology using CDC data, the national prevalence of keratoconus in the U.S. was 0.04% in 2019, with an estimated 132,089 diagnosed Americans, and a cumulative economic burden of $3.8 billion. Understanding how keratoconus progresses and knowing what to watch for can help you take timely action to protect your sight. Keratoconus does not follow the same course for every patient. The rate and severity of progression depend on multiple factors, including your age at diagnosis and overall eye health.

In its earliest stages, keratoconus may produce only mild astigmatism (an uneven curvature of the cornea) and slightly blurred vision. Many patients first notice that their glasses prescription changes more frequently than expected or that vision becomes harder to correct with standard lenses. At this point, a routine eye exam may not reveal obvious abnormalities, which is why specialized corneal imaging is essential for early detection.

As the cornea continues to thin and steepen, astigmatism becomes more irregular and difficult to correct with glasses alone. Patients often experience ghosting or streaking around lights, increased sensitivity to glare, and overall hazier vision. Specialty contact lenses, such as rigid gas permeable or scleral lenses, typically become necessary to achieve clear vision during this stage.

In advanced cases, the cornea may develop scarring at the cone's apex, further reducing visual clarity. Corneal hydrops, a sudden onset of swelling caused by a break in Descemet's membrane (a thin inner layer of the cornea), can occur and temporarily worsen vision significantly. Patients with advanced keratoconus who can no longer achieve functional vision with contact lenses may need to explore procedures such as corneal transplant surgery.

When Keratoconus Typically Stabilizes

When Keratoconus Typically Stabilizes

One of the most common questions patients ask is whether their condition will eventually stop getting worse. While there is no exact age at which keratoconus halts for everyone, research shows a clear pattern related to age. Keratoconus most commonly begins during the teenage years and tends to progress most rapidly between the ages of 10 and 25. Studies show that progression rates are highest in patients 18 years and younger, with approximately 86% of young patients experiencing measurable worsening over time. Children and adolescents diagnosed with keratoconus require especially close monitoring because their corneas are still developing and more vulnerable to change.

For many patients, the cornea gradually stabilizes during the late twenties to mid-thirties as natural corneal cross-linking occurs with age. Progression rates drop significantly after age 35, though they do not disappear entirely. Research has documented a progression rate of approximately 44% in patients 35 and older, particularly in those with more advanced disease. This means that even older patients with keratoconus should continue regular follow-up visits rather than assuming they are out of the woods.

For patients whose keratoconus is actively progressing, corneal cross-linking can strengthen the cornea's structural fibers and slow or halt further changes. This procedure uses riboflavin (vitamin B2) drops and ultraviolet light to create new bonds between collagen fibers in the cornea. Randomized controlled trials have shown that cross-linking prevents further steepening to a statistically significant degree, and the treatment has become a standard intervention in keratoconus management for patients of all ages.

Factors That Cause Keratoconus to Worsen Faster

Several factors are known to accelerate keratoconus progression. Understanding these risk factors can help you make informed decisions about your daily habits and treatment plan. Chronic or vigorous eye rubbing is one of the most well-established modifiable risk factors for keratoconus progression. The mechanical force applied to the cornea during rubbing can weaken already compromised tissue and accelerate thinning and bulging. Patients with allergies, eczema, or habitual eye rubbing should work with their care team to manage itching through medication and break the rubbing cycle entirely.

Conditions such as allergic conjunctivitis, asthma, eczema, and hay fever are associated with a higher risk of keratoconus progression. Research has found that a history of asthma nearly triples the odds of progression. The link may be partly due to increased eye rubbing driven by ocular itching and partly due to inflammatory processes that weaken corneal tissue over time.

Patients diagnosed during childhood or early adolescence face a higher risk of rapid progression. The cornea is still maturing in younger patients, and the disease tends to be more aggressive during these years. Early intervention with corneal cross-linking is especially important for this age group to prevent the need for more invasive treatments later.

A family history of keratoconus increases the likelihood of developing and progressing with the condition. Hormonal changes, including those during pregnancy or puberty, may also influence corneal biomechanics and contribute to worsening. Patients with a known family history should begin screening early and maintain consistent monitoring throughout their lives.

How Keratoconus Progression Is Monitored

Monitoring keratoconus requires more than a standard eye exam. Cornea specialists rely on advanced imaging technologies and clinical measurements to detect subtle changes that indicate progression. Corneal topography uses a Placido disc system to map the curvature of the front surface of the cornea. It generates a color-coded map that highlights areas of steepening, flattening, and irregularity. Topography is considered a gold standard tool for diagnosing keratoconus and tracking changes at each monitoring visit.

Corneal tomography, often performed with a Scheimpflug camera such as the Pentacam, provides a three-dimensional analysis of the entire cornea. This includes front and back surface elevation, corneal thickness at every point, and overall corneal volume. Tomography can detect posterior corneal changes that topography alone may miss, making it especially valuable for identifying early or subtle progression.

Corneal pachymetry measures the thickness of the cornea at its thinnest point and across its full diameter. Progressive thinning at the cone's apex is a hallmark of worsening keratoconus. When combined with topographic and tomographic data, pachymetry helps the care team determine whether cross-linking or other interventions are warranted.

Several specific values help determine whether keratoconus is progressing. These include maximum keratometry (Kmax), which reflects the steepest point on the cornea; thinnest corneal pachymetry, which tracks progressive thinning; anterior and posterior elevation values, which detect bulging on both corneal surfaces; and higher-order aberrations, which measure optical irregularities caused by the cone shape. A change in Kmax of one diopter or more over 12 months is generally considered evidence of progression. Multiple scans at each visit ensure accuracy, and contact lenses should be removed for a consistent period before scanning.

Frequently Asked Questions

Frequently Asked Questions

The primary imaging tests include corneal topography, corneal tomography, and anterior segment optical coherence tomography (OCT). Topography maps the front corneal surface, while tomography evaluates both surfaces and overall thickness in three dimensions. OCT provides high-resolution cross-sectional images and epithelial thickness maps, which may reveal thinning patterns even before topographic changes become apparent.

Yes, eye rubbing is strongly associated with keratoconus progression. The repetitive mechanical trauma weakens the collagen structure of an already thin cornea, which can accelerate bulging and vision loss. If you experience frequent itching due to allergies or other conditions, your care team can recommend allergy management strategies and alternative ways to relieve eye discomfort without rubbing.

Noticeable signs of progression include increasingly blurry or distorted vision, more frequent changes in your glasses or contact lens prescription, worsening glare and halos around lights, and difficulty achieving clear vision even with corrective lenses. However, some progression occurs before you notice symptoms, which is why regular imaging appointments are essential for catching early changes.

Corneal cross-linking has been shown to halt or significantly slow keratoconus progression in the majority of treated eyes. Clinical trials demonstrated that treated corneas remained stable or even flattened slightly, while untreated eyes continued to steepen over three or more years of follow-up. In a small percentage of younger patients, the effect may diminish over time as collagen naturally turns over, and repeat treatment may be considered if progression resumes.

The recommended frequency depends on your age, disease severity, and whether you have undergone cross-linking. Younger patients and those with recently diagnosed or actively progressing keratoconus typically need imaging every three to six months. Patients whose corneas have been stable for several years may be monitored annually. The follow-up schedule is tailored based on your individual risk profile and the trends seen in your imaging over time.

Most keratoconus patients maintain functional vision throughout their lives with appropriate monitoring and treatment. Specialty contact lens fitters can achieve excellent visual correction for the majority of patients using scleral, hybrid, or gas permeable lenses. Cross-linking has dramatically reduced the number of people who eventually require a corneal transplant. Patients who stay engaged with their monitoring schedule typically enjoy favorable long-term outcomes.

What our Patients say


4.8

Reviews

(3,408)